28 March 2019 | News
The total financial implication will be Rs. 1092 crore with DBT and WT contributing Rs.728 crore and Rs.364 crore respectively
image credit- fee.org
The Union Cabinet, chaired by the Prime Minister Narendra Modi, has approved the continuation of the Biomedical Research Career Programme (BRCP), and Wellcome Trust (WT) / DBT India Alliance beyond its initial 10-year term (2008-09 to 2018-29) to a new five year phase (2019-20 to 2023-24) with Department of Biotechnology (DBT) increasing its commitment to two times that of WT.
The total financial implication will be Rs. 1092 crore with DBT and WT contributing Rs.728 crore and Rs.364 crore respectively.
Over its 10 years of funding in a 1:1 partnership, the Programme has fulfilled its objectives of building and nurturing talent of highest global standards in cutting-edge biomedical research in India, which has led to important scientific breakthroughs and applications to meet societal needs.
BRCP has made it attractive for high quality Indian scientists working abroad to return to India, and has increased the number of locations geographically within India where world-class biomedical research is undertaken.
In the extending phase, the Programme would continue to build this capacity as also strengthen clinical research and work towards addressing important health challenges for India. Continuation of the Programme with increased stake from the Government of India is important to bring about these returns.